Absci Corp. (ABSI)
8.88
+0.14
(+1.60%)
USD |
NASDAQ |
Oct 15, 16:00
8.90
+0.02
(+0.23%)
After-Hours: 20:00
Absci Cash from Operations (TTM) : -108.08M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -108.08M |
| March 31, 2026 | -97.39M |
| December 31, 2025 | -92.92M |
| September 30, 2025 | -80.71M |
| June 30, 2025 | -76.41M |
| March 31, 2025 | -76.38M |
| December 31, 2024 | -72.40M |
| September 30, 2024 | -70.36M |
| June 30, 2024 | -59.99M |
| March 31, 2024 | -62.38M |
| December 31, 2023 | -64.64M |
| September 30, 2023 | -68.28M |
| Date | Value |
|---|---|
| June 30, 2023 | -76.96M |
| March 31, 2023 | -80.31M |
| December 31, 2022 | -81.34M |
| September 30, 2022 | -79.85M |
| June 30, 2022 | -82.55M |
| March 31, 2022 | -74.46M |
| December 31, 2021 | -60.60M |
| September 30, 2021 | -46.04M |
| June 30, 2021 | -27.00M |
| March 31, 2021 | -15.83M |
| December 31, 2020 | -10.97M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Twist Bioscience Corp. | -53.07M |
| Prime Medicine, Inc. | -156.05M |
| Beam Therapeutics, Inc. | -359.38M |
| Moderna, Inc. | -1.073B |
| Tenax Therapeutics, Inc. | -46.03M |